Publications by authors named "Rosa Coll"

Claim this Profile
G
Genetic evolution and relapse-associated mutations in adult T-cell acute lymphoblastic leukemia patients treated in PETHEMA trials.
Celia González-Gil, Thaysa Lopes, Mireia Morgades, Francisco Fuster-Tormo, Pau Montesinos, Rosa Coll

Hemasphere· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.
Guadalupe Oñate, Ana Garrido, Montserrat Arnan, Helena Pomares, Ester Alonso, Rosa Coll

Blood Cancer J· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups.
Susana Vives, David Quintela, Mireia Morgades, Isabel Cano-Ferri, Alfons Serrano, Rosa Coll

Cancers (Basel)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Judicious use of smartphones in primary care consultations].
Raisa Maria Iconareasa Sugeac, Rosa Coll

Aten Primaria· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iadademstat in combination with azacitidine in patients with newly diagnosed acute myeloid leukaemia (ALICE): an open-label, phase 2a dose-finding study.
Olga Salamero, Antonieta Molero, José Antonio Pérez-Simón, Montserrat Arnan, Rosa Coll

Lancet Haematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel NUP98 fusion partners and comutations in acute myeloid leukemia: an adult cohort study.
James S Heald, Aleix Méndez López, Miguel L Pato, Neus Ruiz-Xivillé, Marta Cabezón, Rosa Coll

Blood Adv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA.
Ricardo Sánchez, Sara Dorado, Yanira Ruíz-Heredia, Alejandro Martín-Muñoz, Juan Manuel Rosa-Rosa, Rosa Coll

Sci Rep· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.
Guadalupe Oñate, Marta Pratcorona, Ana Garrido, Alicia Artigas-Baleri, Alex Bataller, Rosa Coll

Blood Cancer J· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials.
Celia González-Gil, Mireia Morgades, Thaysa Lopes, Francisco Fuster-Tormo, Jesús García-Chica, Rosa Coll

Haematologica· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the outcomes of newly diagnosed patients with high-risk myelodysplastic syndrome according to the initial therapeutical strategies chosen in usual clinical practice.
Maria Julia Montoro, Helena Pomares, Rosa Coll, Teresa Bernal Del Castillo, Mar Tormo

Leuk Lymphoma· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors.
David Cruz, Rocío Rodríguez-Romanos, Marta González-Bartulos, Irene García-Cadenas, Rafael de la Cámara, Rosa Coll

Front Immunol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Center-related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric-inspired Protocols.
Pere Barba, Mireia Morgades, Pau Montesinos, Jose Gonzalez-Campos, Anna Torrent, Rosa Coll

Hemasphere· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5'-nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate-risk cytogenetics.
Johana Díaz-Santa, Rocío Rodríguez-Romanos, Rosa Coll, Gemma Osca, Marta Pratcorona

Eur J Haematol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post thawing viable CD34+ Cells dose is a better predictor of clinical outcome in lymphoma patients undergoing autologous stem cell transplantation.
Jesus Fernandez-Sojo, Joan Cid, Carmen Azqueta, Elena Valdivia, Lluis Martorell, Rosa Coll

Bone Marrow Transplant· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA.
Ricardo Sánchez, Sara Dorado, Yanira Ruíz-Heredia, Alejandro Martín-Muñoz, Juan Manuel Rosa-Rosa, Rosa Coll

Sci Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemsex: on how to optimize access to postexposure HIV prophylaxis.
David Llorens Poblador, Marta Justicia Garriga, Rosa Coll

Emergencias· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1.
Guadalupe Oñate, Alex Bataller, Ana Garrido, Montserrat Hoyos, Montserrat Arnan, Rosa Coll

Blood Adv· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3-PBX1 treated with measurable residual disease-oriented protocols.
Jordi Ribera, Isabel Granada, Mireia Morgades, Teresa González, Juana Ciudad, Rosa Coll

Br J Haematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol.
Alex Bataller, Ana Garrido, Francesca Guijarro, Guadalupe Oñate, Marina Diaz-Beyá, Rosa Coll

Blood Adv· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational profile and relative telomere length in Chronic Myelomonocytic Leukemia subgroups according to the 2016 World Health Organization classification.
Laura Martinez-Verbo, Natalia Estrada, Marta Cabezón, Laura Palomo, Olga García, Rosa Coll

Leuk Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL).
Eulàlia Genescà, Mireia Morgades, Celia González-Gil, Francisco Fuster-Tormo, Claudia Haferlach, Rosa Coll

Leuk Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain.
Josep-Maria Ribera, Mireia Morgades, Rosa Coll, Pere Barba, Jose-Luis López-Lorenzo

Clin Lymphoma Myeloma Leuk· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials.
Josep-Maria Ribera, Mireia Morgades, Eulàlia Genescà, Eduardo-Cerello Chapchap, Pau Montesinos, Rosa Coll

Hematol Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia.
Josep-Maria Ribera, Mireia Morgades, Juana Ciudad, Pau Montesinos, Jordi Esteve, Rosa Coll

Blood· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors and outcome of COVID-19 in patients with hematological malignancies.
José Luis Piñana, Rodrigo Martino, Irene García-García, Rocío Parody, María Dolores Morales, Rosa Coll

Exp Hematol Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis